After Hours Summary: Pretty quiet ahead of Thanksgiving holiday; YMAB +14.3% on FDA approval of DANYELZA; AMCX +5.6% as it will be moved to the the S&P SmallCap 600After Hours Gainers:
Companies trading higher in after hours in reaction to news: YMAB +14.3% (FDA has approved DANYELZA for neuroblastoma in the bone or bone marrow), AMCX +5.6% (to be moved to the the S&P SmallCap 600), LCA +4.3% (receives New Jersey regulatory approval to acquire Golden Nugget Online Gaming), TRVG +2.7% (Altimeter Capital discloses 4.2% stake)
After Hours Losers:
Companies trading lower in after hours in reaction to news: RRD -6.4% (to be removed from the the S&P SmallCap 600), CERE -3.4% (stock offering), GRBK -2.1% (files for $500 mln mixed shelf offering; also files for offering by selling shareholders), IBIO -1.4% (files for $200 mln mixed securities shelf offering), AAN -0.1% (post spin-off will be added to the S&P SmallCap 600)